|Toxiciy Grade:||5||City/State/Province:||New South Wales|
|Treatments:||Chemotherapy, Surgery||Hospital:||University of New South Wales|
This study involved 44 diffuse malignant peritoneal mesothelioma patients. The average patient age was 51.6 years and 63.6 were male.
Patients received cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and mitomycin.
There were three treatment-related deaths in hospital due to treatment/surgery. Infection, pneumonia, bleeding, and kidney impairment were also reported.
The median overall survival was 44 months.
Correspondence: Dr. D.L. Morris; email: email@example.com